Ph.D. WEI-WU HE - 27 Jan 2026 SCHEDULE 13D/A Report for CASI Pharmaceuticals, Inc. Ordinary Shares (CASI)

Filing Manager
Ph.D. WEI-WU HE
Reporting Manager
WEI-WU HE, Ph.D.
Security
CASI Pharmaceuticals, Inc. Ordinary Shares
Symbol
CASI
Shares outstanding
25,763,032 shares
Disclosed Ownership
8,965,535 shares
Ownership
35%
Form type
SCHEDULE 13D/A
Filing time
29 Jan 2026, 19:21:16 UTC
Date of event
27 Jan 2026
Previous filing
09 Jan 2026
SEC
View on sec.gov

Reporting Managers (7)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
WEI-WU HE, Ph.D. 35% 8,965,535 2,130,550 6,834,985 /s/ Wei-Wu He, Ph.D. Wei-Wu He, Ph.D. 0001542073
HUIYING MEMORIAL FOUNDATION 3.1% 637,644 0 637,644 /s/ Wei-Wu He, Ph.D. Wei-Wu He, Ph.D./President
EMERGING TECHNOLOGY PARTNERS, LLC 5.3% 1,097,341 0 1,097,341 /s/ Wei-Wu He, Ph.D. Wei-Wu He, Ph.D./ Managing Member
ETP Global Fund L.P. 3.7% 753,234 0 753,234 EMERGING TECHNOLOGY PARTNERS, LLC General Partner
ETP BIOHEALTH III FUND, L.P. 1.5% 300,000 0 300,000 EMERGING TECHNOLOGY PARTNERS, LLC General Partner
HE Family GRAT 0.5% 100,000 0 100,000 /s/ Wei-Wu He, Ph.D. Wei-Wu He, Ph.D./Trustee
ETP Global Fund III L.P. 20% 5,000,000 0 5,000,000 /s/ Wei-Wu He, Ph.D. Wei-Wu He, Ph.D./ Managing Member